Ellevest’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Ellevest's REGN Position: Q3 2026 in Review
Ellevest increased its Regeneron Pharmaceuticals (REGN) stake by 4.8% in Q3 2026, buying an estimated $20.4K and bringing the position to 589 shares worth $447K. The position accounts for 0.05% of the portfolio, ranked #271.
Ellevest first reported a position in REGN in Q3 2019 and has held it in 29 quarters since. The position peaked at $702K in Q4 2025. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Ellevest held 589 shares of Regeneron Pharmaceuticals worth $447K as of Q3 2026.
- Ellevest bought 27 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $20.4K.
- Regeneron Pharmaceuticals made up 0.05% of Ellevest's portfolio in Q3 2026, its #271 holding.
- Ellevest first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 29 quarters since.
- Ellevest's Regeneron Pharmaceuticals position peaked at $702K in Q4 2025.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.